FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Related Tags >> FDA   Plavix   Generics   Sanofi Aventis
Syndicate content

Bristol-Myers Squibb News

Most Popular Bristol-Myers Squibb Story

BMS to pay Exelixis $240M for cancer drugs

Bristol-Myers Squibb has snatched up two Exelixis programs that GSK left behind when it ended its six-year collaboration with Exelixis. The development deal covers two cancer therapies--Exelixis'... Read more...

Latest Headlines